Biotech

All Articles

Amgen documents very first phase 3 win for $400M eczema medication

.Amgen has shared (PDF) the 1st stage 3 records on its own $400 thousand dermatitis medicine, connec...

Biogen, UCB document stage 3 lupus win after neglecting earlier trial

.Biogen as well as UCB's depend improving in to phase 3 astride an unsuccessful research study wants...

Aptadir really hopes brand-new RNA inhibitors can reverse difficult cancers cells

.Italian biotech Aptadir Therapeutics has released with the guarantee that its pipeline of preclinic...

Wave surfs DMD excellence to regulators' doors, delivering stockpile

.Surge Life Sciences has actually fulfilled its own target in a Duchenne muscle dystrophy (DMD) rese...

Sanofi plucks brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyi...

Achilles trickles tissue therapy course, braces for layoffs after missing out on 'commercial feasibility' objectives

.Achilles Rehabs has wrecked its own technique. The English biotech is knocking off on its clinical-...

Aligos trumpets stage 2 MASH win, reducing liver body fat around 46%

.Aligos Rehabs is actually heralding a midstage win in metabolic-dysfunction affiliated steatohepati...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work cultivating brand-new antifungals has obtained a significant increase ...

Capricor offers Europe civil liberties to late-stage DMD therapy for $35M

.Possessing currently gathered up the united state civil liberties to Capricor Therapeutics' late-st...

FDA junks adcomm for Applied's uncommon condition drug

.After pushing back the decision meeting for Applied Therapies' metabolic condition medication govor...